The Vanguard Group, Inc. has recently announced that it has increased stake in Lilly(Eli) & Co (NYSE:LLY) by 0.90%. After grabbing 67.15 million shares, the institutional investor is now in possession of 0.6 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.07% having worth around $39.69 billion. Moreover, BlackRock Fund Advisors increased its share by 0.63 million to have a control over 41.0 million shares. And Geode Capital Management LLC raised its holdings to 0.51 million shares by acquiring 15.71 million shares or 1.66% of the stake.
Lilly(Eli) & Co (LLY) concluded trading on 01/03/24 at a closing price of $617.70, with 5.11 million shares of worth about $3.16 billion changed hands on the day. Half year performance of the stock remained positive as price took a surge of 32.64% during that period and on Wednesday the price saw a gain of about 4.31%. Currently the company’s common shares owned by public are about 950.18M shares, out of which, 847.90M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 28 analysts are covering the LLY stock and their offered price forecasts bring an average price target of $645.73. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $727.00 and could fall to a lowest price of $430.00. The stock’s current price level is 4.34% above of average price target set by the analysts, while a rise to estimated low would result in loss of -43.65% for the stock. However, touching the estimated high of $727.00 would mean a gain of 15.03% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 292 times over the past 12 months. They bought 248,926 shares in 92 of the transactions. In 200 selling transactions, insiders dumped 3,279,596 shares.
Vanguard Total Stock Market ETF, Vanguard 500 Index Fund, and Vanguard PRIMECAP Fund are the top 3 mutual funds which are holding stakes in Lilly(Eli) & Co Vanguard Total Stock Market ETF is currently holding 26.78 million shares of worth totaling $15.83 billion. The company recently came buying 36193.0 shares which brought its stake up to 2.82% of the company’s outstanding shares. Vanguard 500 Index Fund bought 90945.0 shares, after which its hold over company’s outstanding shares expand to 2.03%, leaving 19.26 million shares with the mutual fund that have a worth of about $11.38 billion. Vanguard PRIMECAP Fund, after selling 13.22 million shares, have now control over 1.39% of the stake in the company. It holds -0.13 million shares of worth $7.81 billion.
Lilly(Eli) & Co (NYSE: LLY) started trading at $600.00, above $7.8 from concluding price of the previous day. However, the stock later moved at a day high price of 619.84, or with a gain of 4.31%. Stock saw a price change of 8.24% in past 5 days and over the past one month there was a price change of 5.76%. Year-to-date (YTD), LLY shares are showing a performance of 5.97% which increased to 68.84% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $309.20 but also hit the highest price of $629.97 during that period. The average intraday trading volume for Lilly(Eli) & Co shares is 3.25 million. The stock is currently trading 6.12% above its 20-day simple moving average (SMA20), while that difference is up 5.54% for SMA50 and it goes to 24.14% higher than SMA200.
The Vanguard Group, Inc. acquired 67.15 million shares of Lilly(Eli) & Co having value of about $39.69 billion. Data submitted at the U.S SEC by The Vanguard Group, Inc. revealed that the firm now holds 0.6 million shares in the company valued at close to $369702715.5, or have control over 0.90% stake in the company. Lilly(Eli) & Co (NYSE: LLY) currently have 950.18M outstanding shares and institutions hold larger chunk of about 73.41% of that. Holding of mutual funds in the company is about 33.91% while other institutional holders and individual stake holders have control over 39.68% and 11.32% of the stake respectively.
The stock has a current market capitalization of $586.39B and its 3Y-monthly beta is at 0.31. PE ratio of stock for trailing 12 months is 114.02, while it has posted earnings per share of $5.42 in the same period. Its PEG reads 3.97 and has Quick Ratio of 0.82 while making debt-to-equity ratio of 1.80. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for LLY, volatility over the week remained 2.10% while standing at 2.18% over the month.
Analysts are in expectations that Lilly(Eli) & Co (LLY) stock would likely to be making an EPS of $Annaly Capital Management Inc. in the current quarter, while forecast for next quarter EPS is $18.92 and it is $Stocks for next year. For the current quarter EPS, analysts have given the company a lowest target $Ally Financial Inc. which is $SPDR Select Sector Fund – Consu at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $LL Flooring Holdings, Inc. in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -16.82% while it is estimated to increase by 86.74% in next year.
Analysts at 28 brokerage firms have issued recommendations for the Lilly(Eli) & Co (LLY)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.71. Out of those 28 Wall Street analysts, 18 recommended a “Buy” rating, while 5 were in favor recommending the stock as a “Hold” and 1 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Daiwa Securities on December 21, 2023 offering an Outperform rating for the stock and assigned a target price range of between $660 and $610 to it.
